@stoolox19
Active 1 year, 3 months ago
Objective To examine the efficacy, safety, and tolerability of methylphenidate extended-release orally disintegrating tablets (MPH XR-ODT) for the treatment of attention-deficit/hyperactivity disorder (ADHD) during the open-label dose-optimization/stabilization period of a phase 3 laboratory classroom study. Methods Children (6-12 years) […] View
-
Turner Lillelund posted an update 1 year, 3 months ago
Objective To examine the efficacy, safety, and tolerability of methylphenidate extended-release orally disintegrating tablets (MPH XR-ODT) for the treatment of attention-deficit/hyperactivity disorder (ADHD) during the open-label dose-optimization/stabilization period of a phase 3 laboratory classroom study. Methods Children (6-12 years) diagnosed…[Read more]
-
Turner Lillelund became a registered member 1 year, 3 months ago
